AstraZeneca PLC (AZNN) — Capital Reinvestment Ratio
Latest as of December 2025:
0.55x
AstraZeneca PLC (AZNN) has a Capital Reinvestment Ratio of 0.55x as of December 2025, meaning it reinvests 1% of its operating cash flow (MX$2.34 Billion) in capital expenditures (MX$1.29 Billion). See AstraZeneca PLC (AZNN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.55x
Capex / Operating Cash Flow
Operating Cash Flow
MX$2.34 Billion
MXN
Capital Expenditures
MX$1.29 Billion
MXN
Data as of
Dec 2025
Most recent filing
AstraZeneca PLC Capital Reinvestment Ratio (2014–2025)
This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for AstraZeneca PLC (2014–2025)
Year-by-year Capital Reinvestment Ratio for AstraZeneca PLC from 2014 to 2025. For live market cap and broader valuation context, see AZNN stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (MXN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.41x | MX$14.57 Billion | MX$5.91 Billion | ▲ +4.8% |
| 2024 | 0.39x | MX$11.86 Billion | MX$4.59 Billion | ▲ +18.3% |
| 2023 | 0.33x | MX$10.36 Billion | MX$3.39 Billion | ▲ +193.7% |
| 2022 | 0.11x | MX$9.81 Billion | MX$1.09 Billion | ▼ -39.2% |
| 2021 | 0.18x | MX$5.96 Billion | MX$1.09 Billion | ▼ -8.6% |
| 2020 | 0.20x | MX$4.80 Billion | MX$961.00 Million | ▼ -39.3% |
| 2019 | 0.33x | MX$2.97 Billion | MX$979.00 Million | ▼ -17.2% |
| 2018 | 0.40x | MX$2.62 Billion | MX$1.04 Billion | ▲ +7.5% |
| 2017 | 0.37x | MX$3.58 Billion | MX$1.33 Billion | ▼ -33.6% |
| 2016 | 0.56x | MX$4.14 Billion | MX$2.31 Billion | ▲ +39.7% |
| 2015 | 0.40x | MX$3.32 Billion | MX$1.33 Billion | ▲ +178.6% |
| 2014 | 0.14x | MX$7.06 Billion | MX$1.01 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow